The vascular endothelial growth factor system-a new player in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease  

作　　者：Henning Grønbæk Anders Mellemkjær Søren Nielsen Faidon Magkos 

机构地区：[1]Department of Hepatology&Gastroenterology,Aarhus University Hospital,Aarhus,Denmark [2]Clinical Institute,Aarhus University,Aarhus,Denmark [3]Steno Diabetes Center Aarhus,Aarhus University Hospital,Aarhus,Denmark [4]Department of Nutrition,Exercise and Sports,University of Copenhagen,Frederiksberg,Denmark

出　　处：《Hepatobiliary Surgery and Nutrition》2023年第6期963-965,共3页肝胆外科与营养（英文）

摘　　要：The pathogenesis of liver disease from simple steatosis-metabolic dysfunction-associated steatotic liver disease(MASLD)-and the transition to inflammation and fibrosis-metabolic dysfunction-associated steatohepatitis(MASH)-is not well understood.However,cross-talk between subcutaneous white adipose tissue(WAT)and the liver may be of importance.

关 键 词：Vascular endothelial growth factor B(VEGF-B) metabolic dysfunction-associated steatotic liver disease(MASLD) non-alcoholic fatty liver disease(NAFLD) 

分 类 号：R575[医药卫生—消化系统]